Something big happened in medicine, recently.
Scientists designed the first-ever customized drug for just one patient.
It’s called Milasen. And it was designed specifically for, Mila Makovec a young patient who is battling a rare neurological disorder called Batten Disease.
This new frontier of personalized medicine is monumental for the scientific and healthcare communities. And we’re honored to have played a small role in bringing this incredible story to life. We collaborated with Charles River on this powerful story for their “Every Step of the Way” series, a series that tells the stories of their network of dedicated scientists and patients who are making life-changing and life-saving discoveries.
For Mila and Milasen, Charles River played a significant role in producing the drug and performing all of the safety testing in weeks for the FDA, a process that can sometimes take almost a year.
Just one little girl has changed everything we know about drug development. We can’t wait to see what this new future of personalized medicine looks like.
Visit Charles River’s website to learn more: https://www.criver.com/everystep/